Investor List:

Top Pharmaceuticals Pre-Seed Investors in New York City (17)

Know someone who's actively diligencing and investing? Add them to this list.
About this list
We’ve compiled a list of the top Pharmaceuticals investors. The goal is to help Founders find the best investors to target and get introduced to.
Photo of Avi Rosenbaum, Partner at Tectonic Capital
Avi Rosenbaum
Sweet spot: $250K
Range: $50K - $500K
Investors in New York City, Investors in Boston / New England, Investors in SF Bay Area (CA), Investors in San Diego (CA), Investors in Israel, Investors in Europe
Investors in Pharmaceuticals (Pre-seed), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in Pharmaceuticals (Seed), Investors in Medical Devices (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in Medical Devices (Seed), Investors in Medical Devices (Series A), Investors in Medical Devices (Pre-seed), Investors in Medical Devices (Series A), Investors in Pharmaceuticals (Pre-seed), Investors in Food and Beverage (Pre-seed), Investors in Manufacturing (Pre-seed), Investors in Pharmaceuticals (Series A), Investors in Medical Devices (Series A), Investors in Medical Devices (Seed), Investors in Manufacturing (Series A), Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in Manufacturing (Pre-seed), Investors in Manufacturing (Pre-seed), Investors in Pharmaceuticals (Series A), Investors in Health & Hospital Services (Pre-seed), Investors in Food and Beverage (Pre-seed), Investors in Manufacturing (Seed), Investors in AgTech (Pre-seed), Investors in Food and Beverage (Series A), Investors in Food and Beverage (Series A), Investors in Manufacturing (Series A), Investors in Pharmaceuticals (Pre-seed), Investors in AgTech (Pre-seed), Investors in Food and Beverage (Seed), Investors in Medical Devices (Series A), Investors in Medical Devices (Pre-seed), Investors in BioTech (Pre-seed), Investors in Pharmaceuticals (Seed), Investors in Food and Beverage (Seed), Investors in Manufacturing (Seed), Investors in Food and Beverage (Series A), Investors in ClimateTech/CleanTech (Pre-seed), Investors in Food and Beverage (Pre-seed), Investors in AgTech (Series A), Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Series A), Investors in AgTech (Series A), Investors in Pharmaceuticals (Pre-seed), Investors in ClimateTech/CleanTech (Pre-seed), Investors in Consumer Health (Pre-seed), Investors in BioTech (Series A), Investors in Pharmaceuticals (Seed), Investors in Manufacturing (Series A), Investors in Food and Beverage (Seed), Investors in Health & Hospital Services (Series A), Investors in Manufacturing (Series A), Investors in Manufacturing (Seed), Investors in AgTech (Pre-seed), Investors in ClimateTech/CleanTech (Series A), Investors in BioTech (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Manufacturing (Pre-seed), Investors in Manufacturing (Pre-seed), Investors in AgTech (Series A), Investors in AgTech (Seed), Investors in AgTech (Pre-seed), Investors in BioTech (Seed), Investors in Consumer Health (Series A), Investors in Food and Beverage (Pre-seed), Investors in AgTech (Seed), Investors in Consumer Health (Pre-seed), Investors in ClimateTech/CleanTech (Seed), Investors in Health & Hospital Services (Seed), Investors in Consumer Health (Seed), Investors in ClimateTech/CleanTech (Pre-seed), Investors in AgTech (Seed), Investors in Pharmaceuticals (Pre-seed), Investors in Consumer Health (Pre-seed), Investors in ClimateTech/CleanTech (Series A), Investors in Medical Devices (Series A), Investors in Manufacturing (Seed), Investors in Food and Beverage (Series A), Investors in AgTech (Series A), Investors in BioTech (Series A), Investors in Consumer Health (Series A), Investors in Medical Devices (Pre-seed), Investors in Medical Devices (Seed), Investors in Food and Beverage (Pre-seed), Investors in ClimateTech/CleanTech (Series A), Investors in Health & Hospital Services (Pre-seed), Investors in Health & Hospital Services (Series A), Investors in Manufacturing (Series A), Investors in Pharmaceuticals (Series A), Investors in Food and Beverage (Seed), Investors in Pharmaceuticals (Seed), Investors in Consumer Health (Seed), Investors in BioTech (Seed), Investors in BioTech (Pre-seed), Investors in Health & Hospital Services (Seed), Investors in Health & Hospital Services (Pre-seed), Investors in AgTech (Seed), Investors in AI (Pre-seed), Investors in BioTech (Pre-seed), Investors in Food and Beverage (Series A), Investors in ClimateTech/CleanTech (Seed), Investors in AI (Pre-seed), Investors in AgTech (Pre-seed), Investors in Consumer Health (Series A), Investors in ClimateTech/CleanTech (Pre-seed), Investors in ClimateTech/CleanTech (Seed), Investors in Consumer Health (Seed), Investors in Health & Hospital Services (Series A), Investors in AgTech (Series A), Investors in Manufacturing (Seed), Investors in Consumer Health (Pre-seed), Investors in ClimateTech/CleanTech (Series A), Investors in AI (Series A), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in Manufacturing (Pre-seed), Investors in Food and Beverage (Seed), Investors in AI (Series A), Investors in AI (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in AI (Series A), Investors in AgTech (Seed), Investors in Medical Devices (Series A), Investors in Food and Beverage (Pre-seed), Investors in AI (Seed), Investors in Health & Hospital Services (Seed), Investors in ClimateTech/CleanTech (Pre-seed), Investors in Consumer Health (Pre-seed), Investors in Pharmaceuticals (Series A), Investors in Manufacturing (Series A), Investors in Pharmaceuticals (Seed), Investors in Medical Devices (Seed), Investors in BioTech (Seed), Investors in AI (Seed), Investors in ClimateTech/CleanTech (Seed), Investors in Consumer Health (Series A), Investors in AgTech (Pre-seed), Investors in BioTech (Seed), Investors in BioTech (Pre-seed), Investors in Consumer Health (Seed), Investors in AI (Seed), Investors in Food and Beverage (Series A), Investors in Health & Hospital Services (Series A), Investors in AgTech (Series A), Investors in Manufacturing (Seed), Investors in AI (Pre-seed), Investors in Health & Hospital Services (Seed), Investors in ClimateTech/CleanTech (Series A), Investors in Consumer Health (Pre-seed), Investors in Consumer Health (Series A), Investors in Food and Beverage (Seed), Investors in AI (Series A), Investors in Health & Hospital Services (Pre-seed), Investors in AgTech (Seed), Investors in Israel (Other Lists), Investors in Consumer Health (Seed), Investors in ClimateTech/CleanTech (Pre-seed), Investors in ClimateTech/CleanTech (Seed), Investors in BioTech (Pre-seed), Investors in BioTech (Series A), Investors in Los Angeles / Southern California (Other Lists), Investors in Boston / New England (Other Lists), Investors in AI (Seed), Investors in Health & Hospital Services (Series A), Investors in AI (Pre-seed), Investors in BioTech (Seed), Investors in Health & Hospital Services (Seed), Investors in Consumer Health (Series A), Investors in Consumer Health (Seed), Investors in ClimateTech/CleanTech (Series A), Investors in BioTech (Series A), Investors in ClimateTech/CleanTech (Seed), Investors in AI (Series A), Investors in Health & Hospital Services (Series A), Investors in BioTech (Seed), Investors in AI (Pre-seed), Investors in Health & Hospital Services (Seed), Investors in AI (Seed), Investors in New York City (Other Lists), Investors in AI (Series A), Investors in AI (Seed), Investors in San Francisco Bay Area (Other Lists)
Photo of Zach Weinberg, Investor at Curie.Bio
Zach Weinberg
Curie.Bio·Investor
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in New York (NY)
Investors in Pharmaceuticals (Pre-seed), Investors in Pharmaceuticals (Series B), Investors in Pharmaceuticals (Seed), Investors in Pharmaceuticals (Series A), Investors in AI (Series B), Investors in BioTech (Series B), Investors in BioTech (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in AI (Pre-seed), Investors in AI (Series A), Investors in Pharmaceuticals (Series B), Investors in AI (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Seed), Investors in Enterprise (Series B), Investors in SaaS (Pre-seed), Investors in Consumer Internet (Pre-seed), Investors in SaaS (Series B), Investors in Enterprise (Pre-seed), Investors in AI (Pre-seed), Investors in Consumer Internet (Series B), Investors in AI (Series B), Investors in BioTech (Pre-seed), Investors in SaaS (Series A), Investors in BioTech (Series B), Investors in Enterprise (Series A), Investors in AI (Series A), Investors in SaaS (Seed), Investors in Consumer Internet (Series A), Investors in AI (Seed), Investors in Consumer Internet (Seed), Investors in Enterprise (Seed), Investors in Consumer Internet (Pre-seed), Investors in BioTech (Series A), Investors in SaaS (Series B), Investors in Enterprise (Pre-seed), Investors in Consumer Internet (Series B), Investors in BioTech (Seed), Investors in SaaS (Pre-seed), Investors in Enterprise (Series B), Investors in SaaS (Series A), Investors in Consumer Internet (Series A), Investors in Enterprise (Series A), Investors in Consumer Internet (Seed), Investors in SaaS (Seed), Investors in Enterprise (Seed), Investors in Angel, Scout, and Solo-Capitalists (Other Lists), Investors in New York City (Other Lists)
Photo of Pablo Lubroth, Investor at Hummingbird Ventures
Pablo Lubroth
Sweet spot: $2.8M
Range: $500K - $5.0M
Investors in London, Investors in New York (NY)
Investors in Pharmaceuticals (Pre-seed), Investors in Therapeutics (Pre-seed), Investors in Therapeutics (Pre-seed), Investors in Therapeutics (Series A), Investors in Pharmaceuticals (Seed), Investors in Therapeutics (Seed), Investors in Therapeutics (Series B), Investors in Therapeutics (Series B), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Series B), Investors in Pharmaceuticals (Pre-seed), Investors in Therapeutics (Series A), Investors in Therapeutics (Seed), Investors in DeepTech (Series B), Investors in DeepTech (Pre-seed), Investors in Therapeutics (Series B), Investors in Digital Health (Pre-seed), Investors in DeepTech (Series B), Investors in DeepTech (Series A), Investors in DeepTech (Seed), Investors in Pharmaceuticals (Series B), Investors in BioTech (Series B), Investors in Digital Health (Series B), Investors in Therapeutics (Series A), Investors in Digital Health (Series A), Investors in DeepTech (Pre-seed), Investors in BioTech (Pre-seed), Investors in Therapeutics (Pre-seed), Investors in DeepTech (Series A), Investors in Digital Health (Pre-seed), Investors in BioTech (Series A), Investors in Digital Health (Seed), Investors in Therapeutics (Seed), Investors in Pharmaceuticals (Seed), Investors in DeepTech (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in BioTech (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Digital Health (Series B), Investors in Pharmaceuticals (Series B), Investors in DeepTech (Series B), Investors in BioTech (Series A), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in BioTech (Seed), Investors in DeepTech (Pre-seed), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Seed), Investors in Digital Health (Pre-seed), Investors in DeepTech (Series A), Investors in DeepTech (Seed), Investors in Digital Health (Series B), Investors in BioTech (Pre-seed), Investors in BioTech (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in London (Other Lists), Investors in New York City (Other Lists)
Photo of Peter Donnelly, Managing Director at Accelerate New York Seed Fund
Peter Donnelly
Sweet spot: $100K
Range: $100K - $100K
Investors in New York (NY)
Photo of Michael Baran, Partner at Pfizer Venture Investments
Michael Baran
Sweet spot: $10.0M
Range: $100K - $15.0M
Investors in New York City
Investors in Pharmaceuticals (Pre-seed), Investors in Pharmaceuticals (Series B), Investors in BioTech (Pre-seed), Investors in Pharmaceuticals (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series B), Investors in Pharmaceuticals (Pre-seed), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series B), Investors in BioTech (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Pre-seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series B), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in New York City (Other Lists)
Photo of Thanos Papadimitriou, Partner at Charge Ventures
Thanos Papadimitriou
Sweet spot: $250K
Range: $100K - $1M
Investors in New York (NY)
Investors in Pharmaceuticals (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in Medical Devices (Seed), Investors in Medical Devices (Series A), Investors in Pharmaceuticals (Seed), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in AI (Pre-seed), Investors in AI (Series A), Investors in Medical Devices (Series A), Investors in AI (Seed), Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in Pharmaceuticals (Series A), Investors in AI (Pre-seed), Investors in AI (Series A), Investors in AI (Seed), Investors in New York City (Other Lists)
Photo of Gregory Harriman, Partner at BioAdvance
Gregory Harriman
BioAdvance·Partner
Sweet spot: $3.3M
Range: $1.5M - $5.0M
Investors in Washington, Investors in Delaware, Investors in New York City, Investors in Maryland, Investors in Pennsylvania
Photo of Roland Turck, Partner at Boro Capital
Roland Turck
Boro Capital·Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in New York City
Investors in Diagnostics (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Diagnostics (Seed), Investors in Diagnostics (Pre-seed), Investors in BioTech (Pre-seed), Investors in Pharmaceuticals (Seed), Investors in Pharmaceuticals (Pre-seed), Investors in Diagnostics (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Pre-seed), Investors in BioTech (Seed), Investors in New York City (Other Lists)